Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India.

Umadevi KM, Ranganathan K, Pavithra S, Hemalatha R, Saraswathi TR, Kumarasamy N, Solomon S, Greenspan JS.

J Oral Pathol Med. 2007 Mar;36(3):136-41.

PMID:
17305634
2.

The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.

Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, González-Ramírez I, Ponce-de-León S.

Medicine (Baltimore). 2003 Jan;82(1):39-50.

3.
4.
5.

Effect of prolonged HAART on oral colonization with Candida and candidiasis.

Yang YL, Lo HJ, Hung CC, Li Y.

BMC Infect Dis. 2006 Jan 20;6:8.

6.

Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.

Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KA.

J Oral Pathol Med. 2002 Mar;31(3):169-74.

PMID:
11903824
7.

Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.

Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanikolaou IS, Kordossis T.

Oral Dis. 2004 May;10(3):145-50.

PMID:
15089923
8.

Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India.

Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CC, Solomon S, Mayer KH.

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):53-8.

PMID:
16340473
9.

Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.

Ortega KL, Vale DA, Magalhães MH.

J Oral Pathol Med. 2009 Jul;38(6):489-94. doi: 10.1111/j.1600-0714.2009.00783.x. Epub 2009 Apr 28.

PMID:
19453845
10.

Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.

Shah SU, Kerkar SP, Pazare AR.

Br J Ophthalmol. 2009 Jan;93(1):88-90. doi: 10.1136/bjo.2008.149237. Epub 2008 Oct 24.

PMID:
18952644
11.

Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients.

Kerdpon D, Pongsiriwet S, Pangsomboon K, Iamaroon A, Kampoo K, Sretrirutchai S, Geater A, Robison V.

Oral Dis. 2004 May;10(3):138-44.

PMID:
15089922
12.

Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients.

Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW.

Oral Dis. 2000 May;6(3):152-7.

PMID:
10822358
13.

Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.

Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J.

Clin Infect Dis. 2007 Oct 1;45(7):925-32. Epub 2007 Aug 23.

PMID:
17806063
14.

Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies.

Flanagan MA, Barasch A, Koenigsberg SR, Fine D, Houpt M.

Pediatr Dent. 2000 Jul-Aug;22(4):287-91.

PMID:
10969432
15.

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India.

Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, Mayer KH.

AIDS. 2003 Oct 17;17(15):2267-9.

PMID:
14523288
16.

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB; AIDS Clinical Trials Group 328 Study Team.

Arch Intern Med. 2007 Mar 26;167(6):597-605.

PMID:
17389292
17.

Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.

Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R.

Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):264-71. doi: 10.1080/09286580802077716.

PMID:
18780260
18.

Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.

Chattopadhyay A, Caplan DJ, Slade GD, Shugars DC, Tien HC, Patton LL.

Community Dent Oral Epidemiol. 2005 Feb;33(1):35-44.

PMID:
15642045
19.

The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.

Tappuni AR, Fleming GJ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Dec;92(6):623-8.

PMID:
11740479
20.

Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.

Grinsztejn B, Veloso VG, Pilotto JH, Campos DP, Keruly JC, Moore RD.

J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):515-20.

PMID:
17558332

Supplemental Content

Support Center